Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.5M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| MEXER◷◆ |
| 12,563 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | MEXER◷◆ | 62,500 | — | — | — | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 400 | $23.71 | $9.5K | -9.9% | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 9,253 | $22.70 | $210K | -69.6% | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 22,839 | $21.22 | $484.5K | -63.2% | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 5,196 | $19.78 | $102.8K | -12.6% | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | SSELL◷ | 37,375 | $18.91 | $706.8K | -47.5% | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | MEXER◷ | 12,563 | $8.04 | $101K | +19.0% | Open the original filing on SEC.gov |
| May 6 | AVTX | Avalo Therapeutics, Inc. | MEXER◷ | 62,500 | $13.43 | $839.4K | +1,720% | Open the original filing on SEC.gov |